Pharvaris N.V.(NasdaqGS:PHVS) dropped from S&P Global BMI Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.68 USD | +0.35% | -3.28% | -19.14% |
04-15 | Morgan Stanley Adjusts Pharvaris' Price Target to $34 From $35, Keeps Overweight Rating | MT |
04-12 | Pharvaris Files Mixed Shelf | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.14% | 1.22B | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- Pharvaris N.V.(NasdaqGS: PHVS) dropped from S&P Global BMI Index